Genovate Biotechnology Co., Ltd. (4130)
(Delisted)TWSE
26.70
0.00 (0.00%)
Closed
Jul 28, 2026
Day's Range
26.7026.70
52 wk Range
17.6538.89
Overview - 4130 - Genovate Biotechnology Co., Ltd.
Key Statistics
Trading
Average Volume
54.31K
Market Cap - 4130 - Genovate Biotechnology Co., Ltd.
Peers - 4130 - Genovate Biotechnology Co., Ltd.
Peer Comparison
Compared with companies in Biotechnology listed on TWSE.
- 4130TWSEGenovate Biotechnology Co., Ltd.3.65BMarket Cap+29.59%52-week change267.00P/E (Trailing)‪-1.94%‬Profit Margin
- 6696TWSELin BioScience, Inc.138.47BMarket Cap+90.60%52-week change-101.20P/E (Trailing)‪0.00%‬Profit Margin
- 6919TWSECaliway Biopharmaceuticals Co., Ltd.42.55BMarket Cap—52-week change-155.08P/E (Trailing)‪70.55%‬Profit Margin
- 6586TWSECho Pharma Inc.21.50BMarket Cap+61.49%52-week change-74.26P/E (Trailing)‪74.49%‬Profit Margin
- 4728TWSESunmax Biotechnology Co., Ltd.21.29BMarket Cap-5.63%52-week change26.24P/E (Trailing)‪36.97%‬Profit Margin
- 4743TWSEOneness Biotech Co., Ltd.21.05BMarket Cap-60.36%52-week change337.69P/E (Trailing)‪39.54%‬Profit Margin
- 6547TWSEMedigen Vaccine Biologics Corporation20.18BMarket Cap+38.19%52-week change-71.40P/E (Trailing)‪-29.06%‬Profit Margin
Profile Summary - 4130 - Genovate Biotechnology Co., Ltd.
About
Genovate Biotechnology Co., Ltd. is a Taiwan-based healthcare company focused on the research, development, manufacturing, and sale of pharmaceutical products. The company operates as a fully integrated specialty drug maker, offering both finished dosage forms and active pharmaceutical ingredients. Its product…
SectorHealthcare
IndustryBiotechnology
Employees193
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
